McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 24, 4–131 (2022).
Hartupee, J. & Mann, D. L. Neurohormonal activation in heart failure with reduced ejection fraction. Nat. Rev. Cardiol. 14, 30–38 (2017).
CAS PubMed Article Google Scholar
Cohn, J. N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819–823 (1984).
CAS PubMed Article Google Scholar
El-Armouche, A. & Eschenhagen, T. β-Adrenergic stimulation and myocardial function in the failing heart. Heart Fail. Rev. 14, 225–241 (2009).
CAS PubMed Article Google Scholar
McMurray, J. J. et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 371, 993–1004 (2014).
PubMed Article CAS Google Scholar
Armstrong, P. W. et al. Vericiguat in patients with heart failure and reduced ejection fraction. N. Engl. J. Med. 382, 1883–1893 (2020).
CAS PubMed Article Google Scholar
Petraina, A. et al. Cyclic GMP modulating drugs in cardiovascular diseases: Mechanism-based network pharmacology. Cardiovasc. Res. https://doi.org/10.1093/cvr/cvab240 (2021).
Article PubMed Central Google Scholar
Anton, S. E. et al. Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling. Cell 185, 1130–1142 (2022).
CAS PubMed Article Google Scholar
Bock, A. et al. Optical mapping of cAMP signaling at the nanometer scale. Cell 182, 1519–1530 (2020).
CAS PubMed PubMed Central Article Google Scholar
Kokkonen, K. & Kass, D. A. Nanodomain regulation of cardiac cyclic nucleotide signaling by phosphodiesterases. Annu. Rev. Pharmacol. Toxicol. 57, 455–479 (2017).
CAS PubMed Article Google Scholar
Lohse, M. J., Engelhardt, S. & Eschenhagen, T. What is the role of β-adrenergic signaling in heart failure? Circ. Res. 93, 896–906 (2003).
CAS PubMed Article Google Scholar
Nikolaev, V. O. et al. β2-Adrenergic receptor redistribution in heart failure changes cAMP compartmentation. Science 327, 1653–1657 (2010).
CAS PubMed Article Google Scholar
Katz, S. D. et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 111, 310–314 (2005).
Dickey, D. M., Dries, D. L., Margulies, K. B. & Potter, L. R. Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte. J. Mol. Cell Cardiol. 52, 727–732 (2012).
CAS PubMed Article Google Scholar
Packer, M. et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N. Engl. J. Med. 325, 1468–1475 (1991).
CAS PubMed Article Google Scholar
Redfield, M. M. et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309, 1268–1277 (2013).
CAS PubMed Article Google Scholar
Preedy, M. E. J. Cardiac cyclic nucleotide phosphodiesterases: roles and therapeutic potential in heart failure. Cardiovasc. Drugs Ther. 34, 401–417 (2020).
CAS PubMed PubMed Central Article Google Scholar
Chen, S. & Yan, C. An update of cyclic nucleotide phosphodiesterase as a target for cardiac diseases. Expert Opin. Drug Discov. 16, 183–196 (2021).
CAS PubMed Article Google Scholar
Boivin, B. et al. Functional β-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc. Res. 71, 69–78 (2006).
CAS PubMed Article Google Scholar
Nash, C. A., Wei, W., Irannejad, R. & Smrcka, A. V. Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCe to regulate cardiac hypertrophy. Elife 8, e48167 (2019).
CAS PubMed PubMed Central Article Google Scholar
Wang, Y. et al. Intracellular β1-adrenergic receptors and organic cation transporter 3 mediate phospholamban phosphorylation to enhance cardiac contractility. Circ. Res. 128, 246–261 (2021).
CAS PubMed Article Google Scholar
Guellich, A., Mehel, H. & Fischmeister, R. Cyclic AMP synthesis and hydrolysis in the normal and failing heart. Pflügers Arch. 466, 1163–1175 (2014).
CAS PubMed Article Google Scholar
Xiang, Y., Rybin, V. O., Steinberg, S. F. & Kobilka, B. Caveolar localization dictates physiologic signaling of β2-adrenoceptors in neonatal cardiac myocytes. J. Biol. Chem. 277, 34280–34286 (2002).
CAS PubMed Article Google Scholar
Ostrom, R. S. et al. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J. Biol. Chem. 276, 42063–42069 (2001).
CAS PubMed Article Google Scholar
Rybin, V. O., Xu, X., Lisanti, M. P. & Steinberg, S. F. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae: a mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem. 275, 41447–41457 (2000).
CAS PubMed Article Google Scholar
Timofeyev, V. et al. Adenylyl cyclase subtype-specific compartmentalization: differential regulation of L-type Ca2+ current in ventricular myocytes. Circ. Res. 112, 1567–1576 (2013).
CAS PubMed PubMed Central Article Google Scholar
Wang, Z. et al. A cardiac mitochondrial cAMP signaling pathway regulates calcium accumulation, permeability transition and cell death. Cell Death Dis. 7, e2198 (2016).
CAS PubMed PubMed Central Article Google Scholar
Di Benedetto, G., Scalzotto, E., Mongillo, M. & Pozzan, T. Mitochondrial Ca2+ uptake induces cyclic AMP generation in the matrix and modulates organelle ATP levels. Cell Metab. 17, 965–975 (2013).
PubMed Article CAS Google Scholar
Zhang, Y. et al. Cardiomyocyte PKA ablation enhances basal contractility while eliminates cardiac β-adrenergic response without adverse effects on the heart. Circ. Res. 12, 1760–1777 (2019).
Liu, G. et al. Mechanism of adrenergic CaV1.2 stimulation revealed by proximity proteomics. Nature 577, 695–700 (2020).
CAS PubMed PubMed Central Article Google Scholar
Leroy, J. & Fischmeister, R. β-Adrenergic regulation of the L-type Ca2+ current: the missing link eventually discovered. Med. Sci. 36, 569–572 (2020).
Bers, D. M. Cardiac excitation-contraction coupling. Nature 415, 198–205 (2002).
CAS PubMed Article Google Scholar
Hayes, J. S., Brunton, L. L., Brown, J. H., Reese, J. B. & Mayer, S. E. Hormonally specific expression of cardiac protein kinase activity. Proc. Natl Acad. Sci. USA 76, 1570–1574 (1979).
CAS PubMed PubMed Central Article Google Scholar
Lehmann, L. H. et al. A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. Nat. Med. 24, 62–72 (2018).
CAS PubMed Article Google Scholar
Chang, C. W. et al. Acute β-adrenergic activation triggers nuclear import of histone deacetylase 5 and delays Gq-induced transcriptional activation. J. Biol. Chem. 288, 192–204 (2013).
CAS PubMed Article Google Scholar
Ha, C. H. et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. USA 107, 15467–15472 (2010).
CAS PubMed PubMed Central Article Google Scholar
Backs, J. et al. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol. 195, 403–415 (2011).
CAS PubMed PubMed Central Article Google Scholar
Antos, C. L. et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ. Res. 89, 997–1004 (2001).
CAS PubMed Article Google Scholar
Zhang, X. et al. Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling. Circ. Res. 112, 498–509 (2013).
留言 (0)